Nevertheless, Tang et al. [15] revealed that the expression of WBP5 might be higher in patients at the advanced disease stage than at the initial disease stage, suggesting that WBP5 can be a marker for predicting short survival time in patients with SCLC. This evidence concerns the gene TCEAL9 and small cell lung carcinoma.